Divisions of Gastroenterology (Liver Unit) and Critical Care Medicine, University of Alberta, Edmonton, Canada; Institute of Liver Studies, King's College Hospital, Denmark Hill, London, United Kingdom.
Institute of Liver Studies, King's College Hospital, Denmark Hill, London, United Kingdom.
J Crit Care. 2011 Oct;26(5):468-474. doi: 10.1016/j.jcrc.2010.12.018. Epub 2011 Mar 3.
This study aims to investigate what factors predict the development of postoperative bloodstream infection (BSI) in patients transplanted electively for chronic liver disease and compare outcomes in infected transplant recipients (BCLD) with noninfected patients (CLD).
A retrospective cohort study of 218 patients who had elective liver transplantation (LT) between January 2003 and July 2005 and admitted to a specialist intensive care unit (ICU) was done.
Fifteen patients had BSI post-LT (BCLD, 29 isolates) while in the ICU, and 203 patients did not (CLD). Thirty-eight percent of isolates were gram negatives; 55%, gram positives; and 7%, fungemia. Median time to first BSI post-LT was 11 days (range, 3-16 days). On admission post-LT to the ICU, patients with BCLD had higher Acute Physiology and Chronic Health Evaluation II scores (23 vs 10, P < .001). While in the ICU, patients with BCLD had greater requirements for renal replacement therapy (73% vs 8%) and days on mechanical ventilation (17 vs 2 days) and longer median ICU stay (21 vs 3 days, P < .001 for all). One-year survival was worse in the BCLD group (40% vs 94%, P < .001). On multivariate analysis, Acute Physiology and Chronic Health Evaluation II score (odds ratio, 1.36) post-LT was independently associated with subsequent BSI. Bloodstream infection (hazards ratio, 8.7) was independently associated with mortality.
Bloodstream infection post-LT was associated with increased severity of illness on admission, greater requirements for organ support, and increased mortality.
本研究旨在探讨哪些因素可预测择期行肝移植的慢性肝病患者术后血流感染(BSI)的发生,并比较感染移植受者(BCLD)与非感染患者(CLD)的结局。
对 2003 年 1 月至 2005 年 7 月期间行择期肝移植并入住专科重症监护病房(ICU)的 218 例患者进行回顾性队列研究。
15 例患者在肝移植后 ICU 期间发生 BSI(BCLD,29 株分离菌),203 例患者未发生 BSI(CLD)。分离菌中 38%为革兰阴性菌,55%为革兰阳性菌,7%为真菌血症。肝移植后首次发生 BSI 的中位时间为 11 天(范围,3-16 天)。肝移植后入住 ICU 时,BCLD 患者的急性生理与慢性健康状况评分Ⅱ(APACHE Ⅱ)更高(23 分 vs 10 分,P<0.001)。在 ICU 期间,BCLD 患者更需要肾脏替代治疗(73% vs 8%)、机械通气天数(17 天 vs 2 天)和 ICU 中位住院时间更长(21 天 vs 3 天,均 P<0.001)。BCLD 组患者 1 年生存率更差(40% vs 94%,P<0.001)。多变量分析显示,肝移植后 APACHE Ⅱ评分(比值比,1.36)与随后发生 BSI 独立相关。BSI(风险比,8.7)与死亡率独立相关。
肝移植后发生 BSI 与入院时疾病严重程度增加、器官支持需求增加和死亡率增加相关。